Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliane W Schott

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Opinion in Pharmacology|October 4, 2015
Retrovirus-based vectors for transient and permanent cell modificationJuliane W Schott, Dirk Hoffmann, Axel Schambach
Cancer Research|November 4, 2017
Uncoupling the Oncogenic EngineAxel Schambach, Juliane W Schott, Michael A Morgan
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2016
Viral and Synthetic RNA Vector Technologies and ApplicationsJuliane W Schott, Michael Morgan, Melanie Galla, et al.
Hematology/Oncology Clinics of North America|September 13, 2017
Integrating Vectors for Gene Therapy and Clonal Tracking of Engineered HematopoiesisLuca Biasco, Michael Rothe, Juliane W Schott, et al.
Current Gene Therapy|July 27, 2011
Viral and non-viral approaches for transient delivery of mRNA and proteinsJuliane W Schott, Melanie Galla, Tamaryin Godinho, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 7, 2024
The caspase-inhibitor Emricasan efficiently counteracts cisplatin- and neomycin-induced cytotoxicity in cochlear cellsLarissa Nassauer, Juliane W Schott, Jennifer Harre, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 3, 2015
Deciphering the impact of parameters influencing transgene expression kinetics after repeated cell transduction with integration-deficient retroviral vectorsJuliane W Schott, Nico M Jaeschke, Dirk Hoffmann, et al.
Journal of Personalized Medicine|July 2, 2021
Efficient Genetic Safety Switches for Future Application of iPSC-Derived Cell TransplantsJulia Dahlke, Juliane W Schott, Philippe Vollmer Barbosa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 2, 2023
Third-generation lentiviral gene therapy rescues function in a mouse model of Usher 1BJuliane W Schott, Peixin Huang, Michael Morgan, et al.
Molecular Therapy. Nucleic Acids|March 7, 2024
Protection from cisplatin-induced hearing loss with lentiviral vector-mediated ectopic expression of the anti-apoptotic protein BCL-XLLarissa Nassauer, Hinrich Staecker, Peixin Huang, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Opinion in Pharmacology|October 4, 2015
Retrovirus-based vectors for transient and permanent cell modificationJuliane W Schott, Dirk Hoffmann, Axel Schambach
Cancer Research|November 4, 2017
Uncoupling the Oncogenic EngineAxel Schambach, Juliane W Schott, Michael A Morgan
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2016
Viral and Synthetic RNA Vector Technologies and ApplicationsJuliane W Schott, Michael Morgan, Melanie Galla, et al.
Hematology/Oncology Clinics of North America|September 13, 2017
Integrating Vectors for Gene Therapy and Clonal Tracking of Engineered HematopoiesisLuca Biasco, Michael Rothe, Juliane W Schott, et al.
Current Gene Therapy|July 27, 2011
Viral and non-viral approaches for transient delivery of mRNA and proteinsJuliane W Schott, Melanie Galla, Tamaryin Godinho, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 7, 2024
The caspase-inhibitor Emricasan efficiently counteracts cisplatin- and neomycin-induced cytotoxicity in cochlear cellsLarissa Nassauer, Juliane W Schott, Jennifer Harre, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 3, 2015
Deciphering the impact of parameters influencing transgene expression kinetics after repeated cell transduction with integration-deficient retroviral vectorsJuliane W Schott, Nico M Jaeschke, Dirk Hoffmann, et al.
Journal of Personalized Medicine|July 2, 2021
Efficient Genetic Safety Switches for Future Application of iPSC-Derived Cell TransplantsJulia Dahlke, Juliane W Schott, Philippe Vollmer Barbosa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 2, 2023
Third-generation lentiviral gene therapy rescues function in a mouse model of Usher 1BJuliane W Schott, Peixin Huang, Michael Morgan, et al.
Molecular Therapy. Nucleic Acids|March 7, 2024
Protection from cisplatin-induced hearing loss with lentiviral vector-mediated ectopic expression of the anti-apoptotic protein BCL-XLLarissa Nassauer, Hinrich Staecker, Peixin Huang, et al.
Pageof 2